From trials of the first safe polio vaccine to the latest breakthroughs in treatments for neurological diseases, the University of Michigan continues to be at the forefront of pioneering biomedical research that significantly impacts human health. At $1.33 billion, the U-M is the top public university in research spending in the United States, and the Medical School is responsible for almost half of those research expenditures. And with the Fast Forward Medical Innovation program focused on nurturing commercialization and entrepreneurship, the U-M Medical School research enterprise offers a holistic approach to biomedical innovation for both faculty and potential external partners.

The U-M Medical School consistently ranks amongst U.S. News & World Report's top medical research schools, is an NIH Clinical and Translational Research Science Award institution, and is currently undergoing an enterprise-wide initiative to transform clinical trials. While facts like these are impressive, they only hint at what goes on behind the scenes. One of our greatest assets is our collegial, collaborative culture, an atmosphere where faculty, fellows, students, and research teams thrive in the shared pursuit of innovative science and improving patient care.


Thursday, December 03, 2015
5:00 pm to 7:00 pm

G063-64, NCRC Bldg. 10

Academic researchers often look for co-development partnerships with companies, while start-ups seek acquisition. But how do you know when to run down the middle, or when to throw long? Join the Fast Forward Medical Innovation team and BioArbor for this huddle on the ins and outs of industry relationships.

Group: FFMI
Tags: General
Thursday, December 10, 2015
12:00 pm to 2:00 pm

Danto Auditorium, Cardiovascular Center

NEW DATE: Join the Proteomics & Peptide Synthesis Core and MS Bioworks as they discuss clinical applications for quantitative proteomics, including data analysis, experimental design and more.

Group: Research